Company news
Pacira BioSciences, Inc. news in 2023
Pacira BioSciences, Inc.'s news releases, calls and decks from 2023, newest first.
Pacira Appoints Frank D. Lee as Chief Executive Officer
December 20, 2023
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
November 9, 2023
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
November 6, 2023
Pacira BioSciences Reports Third Quarter 2023 Financial Results
November 1, 2023
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
October 25, 2023
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
October 9, 2023
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
October 1, 2023
Pacira BioSciences Announces Leadership Succession Plan
September 25, 2023
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
September 5, 2023
Pacira BioSciences Reports Second Quarter 2023 Financial Results
August 1, 2023
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
July 25, 2023
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
May 30, 2023
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
May 8, 2023
Pacira BioSciences Reports First Quarter 2023 Financial Results
May 2, 2023
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
April 25, 2023
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
April 19, 2023
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
April 18, 2023
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
April 2, 2023
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
March 28, 2023
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
March 21, 2023
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
March 7, 2023
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
February 27, 2023
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
February 22, 2023
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
February 20, 2023
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
January 4, 2023
Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 3, 2023
Calls in 2023
- Pacira BioSciences (NASDAQ:PCRX) Q3 2023 Earnings Call
Nov 2, 2023
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q2 2023 Earnings Call
Aug 2, 2023
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q1 2023 Earnings Call
May 3, 2023
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q4 2022 Earnings Call
Feb 28, 2023
Transcript
Decks in 2023
- Technical Presentation (2023)
Technical · 24 slides · 2023